FOXM1 and posterior cortical atrophy: In prostate cancer (PCa), only few studies focused on the role of FoxM1; for instance, FoxM1 and its target CENPF, a structural protein of kinetochore, have been both proposed as critical drivers of PCa development and as prognostic markers of poor survival [85].